市場調査レポート

臓器保存液の世界市場

Organ Preservation Solutions

発行 Global Industry Analysts, Inc. 商品コード 124548
出版日 ページ情報 英文 113 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
臓器保存液の世界市場 Organ Preservation Solutions
出版日: 2015年09月01日 ページ情報: 英文 113 Pages
概要

当レポートでは、世界の臓器保存液市場について調査し、地域別動向、2014〜2020年の成長予測、および市場に参入する主要な企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • 序論
    • 現在および将来の市場分析
    • 地域別動向
    • 競合シナリオ
    • Custodiol HTKが優勢
    • ViaSpanに関する封じ込め問題
    • 臓器保存技術
    • シンプルな冷蔵保存
    • 継続的低体温潅流
  • 市場動向と成長促進因子
  • 製品概要
    • 臓器保存液の要素と機能
    • 技術仕様
    • 濃縮用溶液
    • 臓器保存のステップ
    • ドナーの特定
    • 臓器摘出
    • 臓器回収と保存
    • 臓器保存技術
    • 低体温
    • 理想的保存液の要件 他
  • 近年の業界活動
  • 主要企業
    • 21st Century Medicine
    • BioLife Solutions, Inc.
    • Claris Injectables Limited
    • Dr. Franz Kohler Chemie GmbH
    • Essential Pharmaceuticals, LLC
    • Lifeline Scientific
    • Preservation Solutions, Inc.
    • XVIVO Perfusion AB
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • その他の諸国

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-6177

This report analyzes the worldwide markets for Organ Preservation Solutions in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 21 companies including many key and niche players such as -

21st Century Medicine
BioLife Solutions, Inc.
Claris Injectables Limited
Dr. Franz Kohler Chemie GmbH
Essential Pharmaceuticals, LLC

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Prelude
  • Current & Future Market Analysis
  • Geographic Landscape
  • Competitive Scenario
    • Table 1: Global Organ Preservation Solutions Market (2011 & 2015): Percentage Breakdown of Dollar Sales for Perfadex, Hypo Thermosol, Custodiol® HTK, Renograf, Viaspan, and Others (includes corresponding Graph/Chart)
  • Custodiol HTK Gains Prominence vs. the Gold Standard UW Solution
  • Contamination Concerns with Regard to ViaSpan®
  • Organ Preservation Techniques
  • Simple Cold Storage
  • Continuous Hypothermic Perfusion/Hypothermic Perfusion Preservation

2. MARKET TRENDS AND GROWTH DRIVERS

  • EVLP: Revolutionary Technique for Lung Preservation
  • New Paradigms in Heart and Lung Preservation
  • Organ Banking: Glimpse into the Future?
  • Preservation Solutions - A Key to Deceased Donor Transplants
  • Euro-Collins Extending Opportunities in the Kidney Segment
  • Cardiac Preservation Scenario Remains Static
  • Lungs Preservation in Search of Ideal Solution
  • Scientists See Cryopreservation as a Potential Means for Organ Preservation
  • Measures to Address Organ Shortage to Infuse Demand for Preservation Solutions
  • Europe and the United States Lead the Global Organ Transplants Market
    • Table 2: Global Organ Transplants by Leading Country in Terms of No. of Transplants Per Million Population (PMP) for the Year 2012 (includes corresponding Graph/Chart)
  • Living Donors on the Rise
    • Table 3: Global Living Organ Donors by Leading Country in Terms of No. of Donors Per Million Population (PMP) for the Year 2013 (includes corresponding Graph/Chart)
    • Table 4: Global Deceased Organ Donors by Leading Country in Terms of No. of Donors Per Million Population (PMP) for the Year 2013 (includes corresponding Graph/Chart)
  • Graying Population and Chronic Diseases Surge Need for Transplants
    • Table 5: Elderly Population (65+ Years) as a % of Total Population (2000 & 2025P) (includes corresponding Graph/Chart)
  • Transplant Tourism - Creating Brighter Avenues
  • Combined Organ Transplantation - Gaining Attention
    • Table 6: Multiple Organ Transplants in the US - No. of Transplants by Type (2010-2015)
  • Cardiac Arrest Death Patients - The Untapped Potential Donors
    • Table 7: Leading Countries in Terms of Number of Donors after Cardiac Death (DCD): 2013 (includes corresponding Graph/Chart)

3. PRODUCT OVERVIEW

  • Elements and Functions of Organ Preservation Solutions
  • Technical Specifications of the Organ Preservation Solutions
  • Solutions in Concentrated Form
  • Steps in Organ Preservation
  • Identification of the Donor
  • Organ Removal
  • Organ Recovery and Preservation
  • Organ Preservation Techniques
  • Hypothermia
  • Requirements of Ideal Preservation Solution
  • Factors Determining Organ Viability
  • Storage Duration Time
  • Storage Time Period for Organs and Tissues
  • Factors Impacting the Organ Preservation
  • Hypothermia Induced Cell Swelling
  • Cellular Acidosis and ATP Usage
  • Compromised Membrane Function
  • Functions of Organ Preservation Solutions
  • Prevention of Reactive Oxygen Species Formation
  • Reduction of Cell Swelling
  • Prevention of Cellular Acidosis
  • Benefits with Colloids
  • Secondary Functions
  • Production and Packaging
  • Production
  • Packaging
  • Tests for Organ Preservation Solutions
  • Hydroxymethylfurfural Test
  • Particulate Contamination
  • Test for Pyrogens
  • Static Cold Storage - The Most Applied and Popular Technique
  • Vitrification - A Promising Cryopreservation Approach for Whole Organs
  • Select Products
  • Euro Collins Solution
    • Composition of Euro-Collins Solution
  • University of Wisconsin (UW) Solution
    • Composition of UW Solution
  • Custodiol® Histidine-Tryptophan-Ketoglutarate (HTK) Solution
    • Composition of Custodial HTK Solution
    • Advantages
    • Disadvantages
    • Major Clinical Differences between Custodiol HTK and Viaspan
  • Celsior Solution
    • Composition of Celsior Solution
  • Hypothermosol
  • Perfadex®
    • Advantages
  • Ross-Marshall Citrate Solutions
  • Phosphate-Buffered Sucrose Solution
  • Lifor
  • IGL-1
  • HBS Solution
  • ET-Kyoto
    • Composition of ET-Kyoto Solution
  • Polysol
  • TranSend
  • Background
  • Organ Transplantation
  • A Prelude
  • Heart Transplantation
    • Heart Diseases and Disorders
    • Post-Operative Complications and Consequences of Heart Transplants
  • Kidney Transplantation
    • Kidney Disorders and Diseases
    • Donor Evaluation
    • Waiting List
    • Surgery/Post-Operation
    • Post-Operative Supervision and Issues
  • Liver Transplantation
    • Liver Disorders and Diseases
  • Pancreas Transplantation
    • Post-Operative Complications and Consequences of Pancreas Transplants
  • Small Intestine Transplantation
    • Intestine Disorders and Diseases
  • Heart-and-Lung Transplantation
  • Lung Transplantation
    • Lung Diseases and Disorders
    • Lung Patients Survival Statistics
  • Transplantation Immunology
    • Acute Cellular Rejection
    • Chronic Rejection
  • Post-Transplant Observations
  • Types of Donors
    • Alive Donors
    • Related Donors
    • Good Samaritans
    • Rewarded/Forced Donors
    • Deceased Donors
    • Directed / Allocated
      • Organs Transplanted by Type of Donor
  • Organ Donation and Eligibility Criteria
    • Factors Considered for Matching Recipients to Donor Organs
    • Testing
      • Blood Typing
      • Tissue Typing
  • Issues Impacting Transplantation Market
    • Scarcity of Donor Organs
    • Organ Rejection
    • Other Issues
  • Ethical Concerns and Bioethical Issues
  • Lack of Requisite Expertise
  • Transplantation - Safety Requirements
  • Waiting List
    • Active Waiting List Patients
    • Inactive Waiting List Patients
  • Transplantation Expenses
    • Major Medical and Non-Medical Expenses
      • Major Milestones in Organ Transplantation

4. RECENT INDUSTRY ACTIVITY

  • Paragonix Technologies Announces Publication of Sherpa Pak™ Transport Systems
  • CFDA Approves Organ Preservation Solutions by Lifeline Scientific
  • Provepharm Enters Into Partnership with DFKC
  • HEMARINA Signs Contract with LFB Biomanufacturing
  • HEMARINA Establishes Operations in the US

5. FOCUS ON SELECT KEY PLAYERS

  • 21st Century Medicine (US)
  • BioLife Solutions, Inc. (US)
  • Claris Injectables Limited (India)
  • Dr. Franz Kohler Chemie GmbH (Germany)
  • Essential Pharmaceuticals, LLC (US)
  • Lifeline Scientific (US)
  • Preservation Solutions, Inc. (US)
  • XVIVO Perfusion AB (Sweden)

6. GLOBAL MARKET PERSPECTIVE

    • Table 8: World Recent Past, Current & Future Analysis for Organ Preservation Solutions by Geographic Region - US, Canada, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 9: World Historic Review for Organ Preservation Solutions by Geographic Region - US, Canada, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 10: World 14-Year Perspective for Organ Preservation Solutions by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Europe, Asia-Pacific, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Increasing Number of Organ Transplants Drives the Organ Preservation Market
    • Table 11: The US Kidney Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept) (includes corresponding Graph/Chart)
    • Table 12: The US Liver Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
    • Table 13: The US Heart Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
    • Table 14: The US Lung Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
    • Table 15: The US Pancreas Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
    • Table 16: The US Intestinal Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
    • Ever-Increasing Waiting Lists Create Demand for Proper Organ Preservation
    • Table 17: The US Waiting List of Patients for Organ Transplants by Organ Type: As of September 2015 (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 18: The US Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: The US Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 20: Canadian Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 21: Canadian Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Table 22: European Deceased Organ Donation Rates Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
    • Table 23: European Living Organ Donation Rates Per Million Population (PMP) by Country for 2013 (includes corresponding Graph/Chart)
    • Table 24: European Single Organ Transplantations by Select Country and Organ Type: 2013 (includes corresponding Graph/Chart)
    • Table 25: European Multi-Organ Transplantations by Select Country and Transplant Type: 2013 (includes corresponding Graph/Chart)
    • Select Countries
      • Italy
      • The United Kingdom
    • Table 26: The UK Organ Donors by Type: May 2015 & May 2014 (includes corresponding Graph/Chart)
    • Table 27: The UK Organ Transplantation by Type: 2014 Vs. 2015 (includes corresponding Graph/Chart)
    • Table 28: The UK Active Transplant Waiting List by Organ: As of April 2014 and April 2015 (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 29: European Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: European Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

  • A. Market Analysis
    • Select Regional Markets
      • Australia
    • Table 31: Australia Organ Transplantations by Organ Type: 2015 (includes corresponding Graph/Chart)
    • Table 32: Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart)
      • China
      • Cost Efficiency Lures Transplant Patients from Overseas
      • India
      • Overview of Renal Transplantation
      • Low Transplantation Expenses Boost Medical Tourism
      • Singapore
      • Awareness Programs to Increase Living Kidney Donations in Singapore
    • Strategic Corporate Development
    • Claris Injectables Limited (India) - A Key Player
  • B. Market Analytics
    • Table 33: Asia-Pacific Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 34: Asia-Pacific Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Select Regional Markets
      • Latin America
      • Brazil - A Major Transplant Market
      • The Middle East
      • Kuwait - A Rapidly Emerging 'Third World' Country in Organ Transplants
      • Iran - "Kidney E-Bay"
  • B. Market Analytics
    • Table 35: Rest of World Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 36: Rest of World Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top